Learn about aducanumab and UNC Neurology’s position on the new drug approved by the FDA for Alzheimer’s disease.

What’s new in the Department of Neurology

Jorge L. Almodóvar-Suárez, MD, associate professor of general neurology and neuromuscular disorders, is the new director of the UNC Department of Neurology’s Amyotrophic Lateral Sclerosis (ALS) Clinic. Born and raised in Puerto Rico, Dr. Almodóvar-Suárez is graduate of the state-funded University of Puerto Rico System, and a faithful believer of education and health care for … Continued

The UNC Department of Neurology is proud to announce that UNC neurologists Clio Rubinos, MD, MS, and Miriam Sklerov, MD, MS, have both received UNC School of Medicine Physician Scientist Training Program Faculty Awards.

The Duke/UNC Alzheimer’s Disease Research Collaborative is offering $50,000 Norins pilot awards to stimulate and support collaborative, innovative research on the potential role of microbes or pathogens in the development of Alzheimer’s disease. The principal investigator must be a Duke University faculty member or postdoctoral fellow, but cross-disciplinary and cross-institutional collaborations is strongly encouraged.

Over 800 scientists from across the United States and overseas convened virtually for a joint Duke/UNC Alzheimer’s Disease Symposium on May 27.

Casey Olm-Shipman, MD, MS, received the High Value Care Award from the UNC School of Medicine Academy of Educators in recognition of her dedication and commitment to improving clinical care though QI research and leadership.

NC TraCS awarded funding for a $5K-$50K grant application submitted by Yen-Yu Ian Shih, PhD.

What’s new in the Department of Neurology

New e-consult service allows referring primary care providers to receive comprehensive and timely recommendations from UNC Department of Neurology specialists.